Policy → market
Market alerts
Not financial advice
Commercial cliffs from presidential documents — role pressure, mechanisms, and a curated issuer watchlist. Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.
How this works
- Cliff vs glide — dates that change market access differ from multi-year programs.
- Role pressure — protective / adverse / mixed for supply-chain roles (not a stock tip).
- Named issuers — curated watchlist only.
- Price window — optional EOD chart around issue and cliff dates; coincidence, not causation.
- in 1dIssued Nov 28, 2025
Initial operating capability demonstration for at least one challenge
ALBAlbemarleGOOGLAlphabetAAPLAppleAMATApplied MaterialsASMLASMLBABoeingAVGOBroadcomLNGCheniere Energy - in 40dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
Tariffs effective for other companies
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - in 96dIssued Nov 28, 2025
First annual report to President on Platform status, outcomes, and partnerships
ALBAlbemarleGOOGLAlphabetAAPLAppleAMATApplied MaterialsASMLASMLBABoeingAVGOBroadcomLNGCheniere Energy - in 225dIssued Mar 27, 2026
Continued national emergency expires unless further extended
ALBAlbemarleAAAlcoaGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBGBungeCATCaterpillarCENXCentury Aluminum - in 884dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
Zero tariff rate expires for companies with MFN pricing agreements
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - in 1321dIssued Apr 9, 2026
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States
20% onshoring rate increases to 100%
MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson - Issued Jul 16, 2026
Regulatory Relief for Certain Stationary Sources To Promote American Chemical Manufacturing Security
This proclamation grants a 2-year exemption from certain EPA emissions-control requirements (the HON Rule) for specific
MMM3MALBAlbemarleAMATApplied MaterialsADMArcher Daniels MidlandASMLASMLBASFYBASFBABoeingAVGOBroadcom - Issued Apr 22, 2026
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs federal agencies to accelerate research, regulatory review, and patient access to psychedel
GOOGLAlphabetAAPLAppleLLYEli LillyQQQInvesco QQQ TrustJNJJohnson & JohnsonMRKMerckMETAMeta PlatformsMSFTMicrosoft - Issued Jul 23, 2025
Regulatory Relief for Certain Stationary Sources To Promote American Chemical Manufacturing Security
This proclamation grants a 2-year exemption from certain EPA emissions-control requirements (the HON Rule) for specific
MMM3MALBAlbemarleAMATApplied MaterialsADMArcher Daniels MidlandASMLASMLBASFYBASFBABoeingAVGOBroadcom - Issued Feb 26, 2025
Defending American Companies and Innovators From Overseas Extortion and Unfair Fines and Penalties
This memorandum directs multiple agencies to investigate and counter foreign tax and regulatory practices—particularly d
EADSYAirbusAAAlcoaGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBABoeingBGBungeCATCaterpillar - Issued Oct 7, 2025
Unlocking Cures for Pediatric Cancer With Artificial Intelligence
This executive order directs the Make America Healthy Again (MAHA) Commission and health agencies to leverage artificial
MMM3MGOOGLAlphabetAAPLAppleCATCaterpillarLLYEli LillyFCXFreeport-McMoRanGEVGE VernovaHONHoneywell